Article
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Scientific reports - 22 Apr 2022
Aggarwal Puja, Hutcheson Katherine A, Yu Robert, Wang Jian, Fuller Clifton D, Garden Adam S, Goepfert Ryan P, Rigert Jillian, Mott Frank E, Lu Charles, Lai Stephen Y, Gunn G Brandon, Chambers Mark S, Li Guojun, Wu Chih-Chieh, Hanna Ehab Y, Sturgis Erich M, Shete Sanjay
Abstract excerpt
Genetic susceptibility for xerostomia, a common sequela of radiotherapy and chemoradiotherapy for head and neck cancer, is unknown. Therefore, to identify genetic variants associated with moderate to severe xerostomia, we conducted a GWAS of 359 long-term oropharyngeal cancer (OPC) survivors using 579,956 autosomal SNPs. Patient-reported cancer treatment-related xerostomia was assessed using the MD Anderson...
Topics
Join the communities discussing this publication.
